NCT06989853View on ClinicalTrials.gov

Methamphetamine and Troriluzole

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 25, 2025

Primary Completion Date

February 28, 2029

Study Completion Date

February 28, 2029

Conditions
Methamphetamine Use Disorder
Interventions
DRUG

Placebo

The effects of placebo will be determined.

DRUG

Methamphetamine

Placebo and methamphetamine will be administered intravenously during experimental sessions.

Trial Locations (1)

40507

RECRUITING

Psychopharmacology of Addiction Laboratory, Lexington

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Kentucky

OTHER

NCT06989853 - Methamphetamine and Troriluzole | Biotech Hunter | Biotech Hunter